These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27316748)

  • 1. Identification of multiple ACVRL1 mutations in patients with pulmonary arterial hypertension by targeted exome capture.
    Piao C; Zhu Y; Zhang C; Xi X; Liu X; Zheng S; Li X; Guo J; Jia L; Nakanishi T; Cai T; Gu H; Du J
    Clin Sci (Lond); 2016 Sep; 130(17):1559-69. PubMed ID: 27316748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation.
    Girerd B; Montani D; Coulet F; Sztrymf B; Yaici A; Jaïs X; Tregouet D; Reis A; Drouin-Garraud V; Fraisse A; Sitbon O; O'Callaghan DS; Simonneau G; Soubrier F; Humbert M
    Am J Respir Crit Care Med; 2010 Apr; 181(8):851-61. PubMed ID: 20056902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACVRL1 germinal mosaic with two mutant alleles in hereditary hemorrhagic telangiectasia associated with pulmonary arterial hypertension.
    Eyries M; Coulet F; Girerd B; Montani D; Humbert M; Lacombe P; Chinet T; Gouya L; Roume J; Axford MM; Pearson CE; Soubrier F
    Clin Genet; 2012 Aug; 82(2):173-9. PubMed ID: 21651515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mutations in BMPR2, ACVRL1 and KCNA5 genes and hemodynamic parameters in patients with pulmonary arterial hypertension.
    Pousada G; Baloira A; Vilariño C; Cifrian JM; Valverde D
    PLoS One; 2014; 9(6):e100261. PubMed ID: 24936649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features of pulmonary arterial hypertension in young people with an ALK1 mutation and hereditary haemorrhagic telangiectasia.
    Smoot LB; Obler D; McElhinney DB; Boardman K; Wu BL; Lip V; Mullen MP
    Arch Dis Child; 2009 Jul; 94(7):506-11. PubMed ID: 19357124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension.
    Fujiwara M; Yagi H; Matsuoka R; Akimoto K; Furutani M; Imamura S; Uehara R; Nakayama T; Takao A; Nakazawa M; Saji T
    Circ J; 2008 Jan; 72(1):127-33. PubMed ID: 18159113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary arterial hypertension and portal hypertension in a patient with hereditary hemorrhagic telangiectasia.
    Pousada G; Baloira A; Valverde D
    Med Clin (Barc); 2015 Mar; 144(6):261-4. PubMed ID: 25543221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia.
    Rigelsky CM; Jennings C; Lehtonen R; Minai OA; Eng C; Aldred MA
    Am J Med Genet A; 2008 Oct; 146A(19):2551-6. PubMed ID: 18792970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of ENG and ACVRL1 (ALK1) mutations in French HHT patients.
    Lesca G; Burnichon N; Raux G; Tosi M; Pinson S; Marion MJ; Babin E; Gilbert-Dussardier B; Rivière S; Goizet C; Faivre L; Plauchu H; Frébourg T; Calender A; Giraud S;
    Hum Mutat; 2006 Jun; 27(6):598. PubMed ID: 16705692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics and genomics of pulmonary arterial hypertension.
    Soubrier F; Chung WK; Machado R; Grünig E; Aldred M; Geraci M; Loyd JE; Elliott CG; Trembath RC; Newman JH; Humbert M
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D13-21. PubMed ID: 24355637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation analysis in hereditary haemorrhagic telangiectasia in Germany reveals 11 novel ENG and 12 novel ACVRL1/ALK1 mutations.
    Wehner LE; Folz BJ; Argyriou L; Twelkemeyer S; Teske U; Geisthoff UW; Werner JA; Engel W; Nayernia K
    Clin Genet; 2006 Mar; 69(3):239-45. PubMed ID: 16542389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia.
    Abdalla SA; Gallione CJ; Barst RJ; Horn EM; Knowles JA; Marchuk DA; Letarte M; Morse JH
    Eur Respir J; 2004 Mar; 23(3):373-7. PubMed ID: 15065824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure and pulmonary arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia type 2.
    Du J; Zhu Y; Zhang YL; Li S; Huang J; Luo XH; Liu L
    J Thromb Thrombolysis; 2015 Nov; 40(4):515-9. PubMed ID: 26245826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of a significant association between mutations in the ACVRL1 gene and hepatic involvement in German patients with hereditary haemorrhagic telangiectasia.
    Brakensiek K; Frye-Boukhriss H; Mälzer M; Abramowicz M; Bahr MJ; von Beckerath N; Bergmann C; Caselitz M; Holinski-Feder E; Muschke P; Oexle K; Strobl-Wildemann G; Wolff G; El-Harith EA; Stuhrmann M
    Clin Genet; 2008 Aug; 74(2):171-7. PubMed ID: 18498373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome sequencing reveals a deep intronic splicing
    Wooderchak-Donahue WL; McDonald J; Farrell A; Akay G; Velinder M; Johnson P; VanSant-Webb C; Margraf R; Briggs E; Whitehead KJ; Thomson J; Lin AE; Pyeritz RE; Marth G; Bayrak-Toydemir P
    J Med Genet; 2018 Dec; 55(12):824-830. PubMed ID: 30244195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic and genetic analysis in children with idiopathic, heritable, and congenital heart disease associated pulmonary arterial hypertension.
    Pfarr N; Fischer C; Ehlken N; Becker-Grünig T; López-González V; Gorenflo M; Hager A; Hinderhofer K; Miera O; Nagel C; Schranz D; Grünig E
    Respir Res; 2013 Jan; 14(1):3. PubMed ID: 23298310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and splicing defect analysis of 23 ACVRL1 mutations in a cohort of patients affected by Hereditary Hemorrhagic Telangiectasia.
    Alaa El Din F; Patri S; Thoreau V; Rodriguez-Ballesteros M; Hamade E; Bailly S; Gilbert-Dussardier B; Abou Merhi R; Kitzis A
    PLoS One; 2015; 10(7):e0132111. PubMed ID: 26176610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of genetic mutation and modifier genes in pulmonary arterial hypertension].
    Fujiwara M; Yagi H; Matsuoka R; Saji T
    Nihon Rinsho; 2008 Nov; 66(11):2071-5. PubMed ID: 19051722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary arterial hypertension in hereditary hemorrhagic telangiectasia associated with ACVRL1 mutation: a case report.
    Walsh LJ; Collins C; Ibrahim H; Kerins DM; Brady AP; O Connor TM
    J Med Case Rep; 2022 Mar; 16(1):99. PubMed ID: 35232468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic counselling in a national referral centre for pulmonary hypertension.
    Girerd B; Montani D; Jaïs X; Eyries M; Yaici A; Sztrymf B; Savale L; Parent F; Coulet F; Godinas L; Lau EM; Tamura Y; Sitbon O; Soubrier F; Simonneau G; Humbert M
    Eur Respir J; 2016 Feb; 47(2):541-52. PubMed ID: 26699722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.